ARCHIVES

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

Two New Communications Contracts Approved

October 18, 1985